 | • レポートコード：QYR9ST03395 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん検査の世界市場について調査・分析し、がん検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（臨床検査、遺伝子検査、イメージング、内視鏡検査）、用途別（膀胱がん検査、乳がん検査、子宮頸がん検査、大腸がん検査、卵巣がん検査、前立腺がん検査、肝がん検査、フローサイトメトリー、その他の臓器特異的がん検査）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん検査市場動向 ・主要企業別マーケットシェア ・がん検査の種類別市場規模2014-2019 （臨床検査、遺伝子検査、イメージング、内視鏡検査） ・がん検査の用途別市場規模2014-2019 （膀胱がん検査、乳がん検査、子宮頸がん検査、大腸がん検査、卵巣がん検査、前立腺がん検査、肝がん検査、フローサイトメトリー、その他の臓器特異的がん検査） ・がん検査の北米市場：主要企業・種類別/用途別市場規模 ・がん検査のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん検査の中国市場：主要企業・種類別/用途別市場規模 ・がん検査の日本国内市場：主要企業・種類別/用途別市場規模 ・がん検査の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん検査のインド市場：主要企業・種類別/用途別市場規模 ・がん検査の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott、Radient Pharmaceuticals、BD Diagnostics、Beckman Coulter、BioCurex、bioMerieux、Cepheid、CytoCore、DiagnoCure、Gen-Probe、Genomic Health、QIAGEN Marseille (Earlier Ipsogen)、Myriad Genetics、Panacea Pharmaceuticals、Qiagen、Siemens Heathcare Diagnostics、Roche、Ventana Medical Systems、Trovagene、Vermillion） ・がん検査の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Therefore, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.
In 2018, the global Cancer Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Test development in United States, Europe and China.
The key players covered in this study
Abbott
Radient Pharmaceuticals
BD Diagnostics
Beckman Coulter
BioCurex
bioMerieux
Cepheid
CytoCore
DiagnoCure
Gen-Probe
Genomic Health
QIAGEN Marseille (Earlier Ipsogen)
Myriad Genetics
Panacea Pharmaceuticals
Qiagen
Siemens Heathcare Diagnostics
Roche
Ventana Medical Systems
Trovagene
Vermillion
Market segment by Type, the product can be split into
Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Market segment by Application, split into
Bladder Cancer Test
Breast Cancer Test
Cervical Cancer Test
Colorectal (Colon) Cancer Test
Ovarian Cancer Test
Prostate Cancer Test
Liver Cancer Test
Flow Cytometry
Other Organ Specific Cancer Test
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Test status, future forecast, growth opportunity, key market and key players.
To present the Cancer Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Test Market Size Growth Rate by Type (2014-2025)
1.4.2 Laboratory Tests
1.4.3 Genetic Tests
1.4.4 Imaging
1.4.5 Endoscopy
1.5 Market by Application
1.5.1 Global Cancer Test Market Share by Application (2014-2025)
1.5.2 Bladder Cancer Test
1.5.3 Breast Cancer Test
1.5.4 Cervical Cancer Test
1.5.5 Colorectal (Colon) Cancer Test
1.5.6 Ovarian Cancer Test
1.5.7 Prostate Cancer Test
1.5.8 Liver Cancer Test
1.5.9 Flow Cytometry
1.5.10 Other Organ Specific Cancer Test
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Test Market Size
2.2 Cancer Test Growth Trends by Regions
2.2.1 Cancer Test Market Size by Regions (2014-2025)
2.2.2 Cancer Test Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Test Market Size by Manufacturers
3.1.1 Global Cancer Test Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Test Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Test Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Test Key Players Head office and Area Served
3.3 Key Players Cancer Test Product/Solution/Service
3.4 Date of Enter into Cancer Test Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Test Market Size by Type (2014-2019)
4.2 Global Cancer Test Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Test Market Size (2014-2019)
5.2 Cancer Test Key Players in United States
5.3 United States Cancer Test Market Size by Type
5.4 United States Cancer Test Market Size by Application
6 Europe
6.1 Europe Cancer Test Market Size (2014-2019)
6.2 Cancer Test Key Players in Europe
6.3 Europe Cancer Test Market Size by Type
6.4 Europe Cancer Test Market Size by Application
7 China
7.1 China Cancer Test Market Size (2014-2019)
7.2 Cancer Test Key Players in China
7.3 China Cancer Test Market Size by Type
7.4 China Cancer Test Market Size by Application
8 Japan
8.1 Japan Cancer Test Market Size (2014-2019)
8.2 Cancer Test Key Players in Japan
8.3 Japan Cancer Test Market Size by Type
8.4 Japan Cancer Test Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Test Market Size (2014-2019)
9.2 Cancer Test Key Players in Southeast Asia
9.3 Southeast Asia Cancer Test Market Size by Type
9.4 Southeast Asia Cancer Test Market Size by Application
10 India
10.1 India Cancer Test Market Size (2014-2019)
10.2 Cancer Test Key Players in India
10.3 India Cancer Test Market Size by Type
10.4 India Cancer Test Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Test Market Size (2014-2019)
11.2 Cancer Test Key Players in Central & South America
11.3 Central & South America Cancer Test Market Size by Type
11.4 Central & South America Cancer Test Market Size by Application
12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Test Introduction
12.1.4 Abbott Revenue in Cancer Test Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Radient Pharmaceuticals
12.2.1 Radient Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Test Introduction
12.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2014-2019)
12.2.5 Radient Pharmaceuticals Recent Development
12.3 BD Diagnostics
12.3.1 BD Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Test Introduction
12.3.4 BD Diagnostics Revenue in Cancer Test Business (2014-2019)
12.3.5 BD Diagnostics Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Test Introduction
12.4.4 Beckman Coulter Revenue in Cancer Test Business (2014-2019)
12.4.5 Beckman Coulter Recent Development
12.5 BioCurex
12.5.1 BioCurex Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Test Introduction
12.5.4 BioCurex Revenue in Cancer Test Business (2014-2019)
12.5.5 BioCurex Recent Development
12.6 bioMerieux
12.6.1 bioMerieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Test Introduction
12.6.4 bioMerieux Revenue in Cancer Test Business (2014-2019)
12.6.5 bioMerieux Recent Development
12.7 Cepheid
12.7.1 Cepheid Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Test Introduction
12.7.4 Cepheid Revenue in Cancer Test Business (2014-2019)
12.7.5 Cepheid Recent Development
12.8 CytoCore
12.8.1 CytoCore Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Test Introduction
12.8.4 CytoCore Revenue in Cancer Test Business (2014-2019)
12.8.5 CytoCore Recent Development
12.9 DiagnoCure
12.9.1 DiagnoCure Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Test Introduction
12.9.4 DiagnoCure Revenue in Cancer Test Business (2014-2019)
12.9.5 DiagnoCure Recent Development
12.10 Gen-Probe
12.10.1 Gen-Probe Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Test Introduction
12.10.4 Gen-Probe Revenue in Cancer Test Business (2014-2019)
12.10.5 Gen-Probe Recent Development
12.11 Genomic Health
12.12 QIAGEN Marseille (Earlier Ipsogen)
12.13 Myriad Genetics
12.14 Panacea Pharmaceuticals
12.15 Qiagen
12.16 Siemens Heathcare Diagnostics
12.17 Roche
12.18 Ventana Medical Systems
12.19 Trovagene
12.20 Vermillion
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Test Key Market Segments
Table Key Players Cancer Test Covered
Table Global Cancer Test Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Test Market Size Market Share by Type 2014-2025
Figure Laboratory Tests Figures
Table Key Players of Laboratory Tests
Figure Genetic Tests Figures
Table Key Players of Genetic Tests
Figure Imaging Figures
Table Key Players of Imaging
Figure Endoscopy Figures
Table Key Players of Endoscopy
Table Global Cancer Test Market Size Growth by Application 2014-2025 (Million US$)
Figure Bladder Cancer Test Case Studies
Figure Breast Cancer Test Case Studies
Figure Cervical Cancer Test Case Studies
Figure Colorectal (Colon) Cancer Test Case Studies
Figure Ovarian Cancer Test Case Studies
Figure Prostate Cancer Test Case Studies
Figure Liver Cancer Test Case Studies
Figure Flow Cytometry Case Studies
Figure Other Organ Specific Cancer Test Case Studies
Figure Cancer Test Report Years Considered
Table Global Cancer Test Market Size 2014-2025 (Million US$)
Figure Global Cancer Test Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Test Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Test Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Test Market Share by Regions 2014-2019
Figure Global Cancer Test Market Share by Regions 2014-2019
Figure Global Cancer Test Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Test Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Test Market Share by Manufacturers (2014-2019)
Figure Global Cancer Test Market Share by Manufacturers in 2018
Table Global Cancer Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Test Product/Solution/Service
Table Date of Enter into Cancer Test Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Test Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Test Market Size Share by Type (2014-2019)
Figure Global Cancer Test Market Size Market Share by Type (2014-2019)
Table Global Cancer Test Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Test Market Size Share by Application (2014-2019)
Figure Global Cancer Test Market Size Market Share by Application (2014-2019)
Figure Global Cancer Test Revenue Market Share by Application in 2018
Figure United States Cancer Test Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Test Market Share (2018-2019)
Table United States Cancer Test Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Test Market Share by Type (2014-2019)
Table United States Cancer Test Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Test Market Share by Application (2014-2019)
Figure Europe Cancer Test Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Test Market Share (2018-2019)
Table Europe Cancer Test Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Test Market Share by Type (2014-2019)
Table Europe Cancer Test Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Test Market Share by Application (2014-2019)
Figure China Cancer Test Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Test Market Share (2018-2019)
Table China Cancer Test Market Size by Type (2014-20189) (Million US$)
Table China Cancer Test Market Share by Type (2014-2019)
Table China Cancer Test Market Size by Application (2014-2019) (Million US$)
Table China Cancer Test Market Share by Application (2014-2019)
Figure Japan Cancer Test Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Test Market Share (2018-2019)
Table Japan Cancer Test Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Test Market Share by Type (2014-2019)
Table Japan Cancer Test Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Test Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Test Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Test Market Share (2018-2019)
Table Southeast Asia Cancer Test Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Test Market Share by Type (2014-2019)
Table Southeast Asia Cancer Test Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Test Market Share by Application (2014-2019)
Figure India Cancer Test Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Test Market Share (2018-2019)
Table India Cancer Test Market Size by Type (2014-2019) (Million US$)
Table India Cancer Test Market Share by Type (2014-2019)
Table India Cancer Test Market Size by Application (2014-2019) (Million US$)
Table India Cancer Test Market Share by Application (2014-2019)
Figure Central & South America Cancer Test Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Test Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Test Market Share (2018-2019)
Table Central & South America Cancer Test Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Test Market Share by Type (2014-2019)
Table Central & South America Cancer Test Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Test Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Cancer Test Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Cancer Test Business (2014-2019)
Table Abbott Recent Development
Table Radient Pharmaceuticals Company Details
Table Radient Pharmaceuticals Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure Radient Pharmaceuticals Revenue Growth Rate in Cancer Test Business (2014-2019)
Table Radient Pharmaceuticals Recent Development
Table BD Diagnostics Company Details
Table BD Diagnostics Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure BD Diagnostics Revenue Growth Rate in Cancer Test Business (2014-2019)
Table BD Diagnostics Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Cancer Test Business (2014-2019)
Table Beckman Coulter Recent Development
Table BioCurex Company Details
Table BioCurex Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure BioCurex Revenue Growth Rate in Cancer Test Business (2014-2019)
Table BioCurex Recent Development
Table bioMerieux Company Details
Table bioMerieux Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure bioMerieux Revenue Growth Rate in Cancer Test Business (2014-2019)
Table bioMerieux Recent Development
Table Cepheid Company Details
Table Cepheid Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure Cepheid Revenue Growth Rate in Cancer Test Business (2014-2019)
Table Cepheid Recent Development
Table CytoCore Company Details
Table CytoCore Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure CytoCore Revenue Growth Rate in Cancer Test Business (2014-2019)
Table CytoCore Recent Development
Table DiagnoCure Company Details
Table DiagnoCure Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure DiagnoCure Revenue Growth Rate in Cancer Test Business (2014-2019)
Table DiagnoCure Recent Development
Table Gen-Probe Company Details
Table Gen-Probe Revenue in Cancer Test Business (2014-2019)(Million US$)
Figure Gen-Probe Revenue Growth Rate in Cancer Test Business (2014-2019)
Table Gen-Probe Recent Development
Table Genomic Health Company Details
Table QIAGEN Marseille (Earlier Ipsogen) Company Details
Table Myriad Genetics Company Details
Table Panacea Pharmaceuticals Company Details
Table Qiagen Company Details
Table Siemens Heathcare Diagnostics Company Details
Table Roche Company Details
Table Ventana Medical Systems Company Details
Table Trovagene Company Details
Table Vermillion Company Details
Table Global Cancer Test Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Test Market Size Share by Regions (2019-2025)
Figure Global Cancer Test Market Size Share by Regions in 2025
Figure United States Cancer Test Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Test Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Test Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Test Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Test Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Test Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Test Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Test Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Test Market Size by Product (2019-2025)
Figure Global Cancer Test Market Size by Product in 2025
Table Global Cancer Test Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Test Market Size by Application (2019-2025)
Figure Global Cancer Test Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
子宮頸がん検査の世界市場：市場規模・現状・予測 Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA …- 子宮頸が診断検査の世界市場：市場規模・現状・予測 Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body.In 2018, the global Cervical Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the en…
- 乳がんスクリーニング検査の世界市場：市場規模・現状・予測 Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- 体外大腸癌スクリーニング検査の世界市場：市場規模・現状・予測 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal can…
- 膀胱がん臨床試験の世界市場：市場規模・現状・予測 Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. ... This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearb…